Copy For Citation
Etcil M., Dedeturk B. K., Kolukisa B., Bakir‐Gungor B., Gungor V. C.
CONCURRENCY COMPUTATION PRACTICE AND EXPERIENCE, vol.37, no.12-14, pp.70107, 2025 (SCI-Expanded)
-
Publication Type:
Article / Article
-
Volume:
37
Issue:
12-14
-
Publication Date:
2025
-
Doi Number:
10.1002/cpe.70107
-
Journal Name:
CONCURRENCY COMPUTATION PRACTICE AND EXPERIENCE
-
Journal Indexes:
Science Citation Index Expanded (SCI-EXPANDED), Scopus, Aerospace Database, Applied Science & Technology Source, Communication Abstracts, Compendex, Computer & Applied Sciences, INSPEC, Metadex, zbMATH, Civil Engineering Abstracts
-
Page Numbers:
pp.70107
-
Kayseri University Affiliated:
Yes
Abstract
ABSTRACTBreast cancer is one of the most widespread kinds of cancer, especially in women, and it has a high mortality rate. With the help of technology, it is possible to develop a computer‐aided method for the diagnosis of breast cancer, which is crucial for effective treatment. Recent breast cancer diagnosis studies utilizing numerous machine learning models were efficient and innovative. However, it has been observed that they may have problems such as long training times and low accuracy rates. To this end, in this study, we present a new classifier that utilizes a hybrid of the clonal selection algorithm (CSA) and the particle swarm optimization (PSO) algorithm for the training of the logistic regression (LR) model, which is named CSA‐PSO‐LR. The proposed method is evaluated using two publicly accessible breast cancer datasets, that is, the Wisconsin Diagnostic Breast Cancer (WDBC) database and the Wisconsin Breast Cancer Database (WBCD), with 10‐fold cross‐validation and Bayesian hyperparameter optimization techniques. Additionally, a CPU parallelization method is applied, which substantially shortens the training time of the model. The efficacy of the CSA‐PSO‐LR classifier is compared with state‐of‐the‐art machine learning algorithms and related studies in the literature. Performance analysis indicates that the proposed method achieves 98.75% accuracy and 98.27% F1‐score on the WDBC dataset, and 97.94% accuracy and 97.35% F1‐score on the WBCD dataset. These results demonstrate the potential of the proposed method as an effective approach for improving breast cancer diagnosis.